Table 3.
Correlates of recent cocaine use (N = 48).
Recent Cocaine Use (n = 24) | No Recent Cocaine Use (n = 24) | |||
---|---|---|---|---|
M (SD) | M (SD) | p-value | ||
Age | 52.5 (9.3) | 50.2 (10.5) | t(46) = −0.81 | 0.422 |
BMI | 29.0 (6.8) | 28.2 (6.0) | t(45) = −0.44 | 0.664 |
Time since HIV diagnosis (years) | 16.9 (8.5) | 13.4 (7.9) | t(44) = −1.46 | 0.152 |
ART adherence (range 0% to 100%) | 97.6 (4.3) | 95.6 (11.3) | t(46) = −0.83 | 0.408 |
Years since began ART | 15.0 (8.5) | 12.6 (7.5) | t(45) = −1.02 | 0.311 |
Proviral HIV DNA (Log10) | 1.9 (0.7) | 1.7 (0.8) | t(46) = −0.72 | 0.477 |
Intracellular HIV RNA (Log10) | −0.1 (0.5) | −0.1 (0.6) | t(46) = 0.21 | 0.837 |
Duration of viral suppression (months) | 19.9 (13.0) | 26.9 (10.6) | t(46) = 2.04 | 0.047 |
VACS Index (range 0 to 164 [riskiest]) | 26.6 (18.7) | 22.9 (13.1) | t(42) = −0.77 | 0.447 |
PTSD Total Severity | 18.0 (15.1) | 16.2 (17.4) | t(46) = −0.40 | 0.693 |
n (%) | n (%) | |||
Black/African American | 19 (79.2%) | 18 (75.0%) | χ2(1) = 0.12 | 0.731 |
Reactive Urine Toxicology for Cannabis | 8 (34.8%) | 3 (13.6%) | χ2(1) = 2.72 | 0.099 |
ART = antiretroviral treatment; BMI = Body Mass Index; PTSD = Post-Traumatic Stress Disorder VACS = Veteran’s Aging Cohort Study